【レポートの概要（一部）】
1 Table of Contents
1 Table of Contents 11
1.1 List of Tables 17
1.2 List of Figures 24
2 Introduction 26
2.1 Catalyst 26
2.2 Related Reports 28
2.3 Upcoming Related Reports 28
3 Disease Overview 29
3.1 Etiology and Pathophysiology 29
3.1.1 Etiology 29
3.1.2 Pathophysiology 31
3.2 Symptoms 35
3.3 Prognosis 35
3.4 Quality of Life 35
4 Epidemiology 36
4.1 Risk Factors and Comorbidities 36
4.2 Global and Historical Trends 37
4.2.1 US 38
4.2.2 5EU 38
4.2.3 Asia 40
4.3 Forecast Methodology 41
4.3.1 Sources Used 49
4.3.2 Forecast Assumptions and Methods 55
4.3.3 Sources Not Used 81
4.4 Prevalent Cases of Dyslipidemia 82
4.4.1 Total Prevalent Cases of Dyslipidemia 82
4.4.2 Age-Specific Total Prevalent Cases of Dyslipidemia 83
4.4.3 Sex-Specific Total Prevalent Cases of Dyslipidemia 85
4.4.4 Age-Standardized Total Prevalence of Dyslipidemia 87
4.5 Epidemiological Forecast for Familial Hypercholesterolemia (2013-2023) 88
4.5.1 Total Prevalent Cases of Familial Hypercholesterolemia 88
4.6 Epidemiological Forecast for Increased LDL-C (2013-2023) 89
4.6.1 Total Prevalent Cases of Increased LDL-C 89
4.6.2 Age-Specific Total Prevalent Cases of Increased LDL-C 91
4.6.3 Sex-Specific Total Prevalent Cases of Increased LDL-C 93
4.6.4 Age-Standardized Total Prevalence of Increased LDL-C 95
4.7 Epidemiological Forecast for Very High TG (≥500mg/dL) (2013-2023) 96
4.7.1 Total Prevalent Cases of Very High TG (≥500mg/dL) 96
4.7.2 Age-Specific Total Prevalent Cases of Very High TG (≥500mg/dL) 98
4.7.3 Sex-Specific Total Prevalent Cases of Very High TG (≥500mg/dL) 100
4.7.4 Age-Standardized Total Prevalence of Very High TG (≥500mg/dL) 102
4.8 Discussion 103
4.8.1 Epidemiological Forecast Insight 103
4.8.2 Limitations of the Analysis 104
4.8.3 Strengths of the Analysis 105
5 Disease Management 106
5.1 Diagnosis and Treatment Overview 106
5.1.1 Diagnosis 106
5.1.2 Treatment Guidelines and Leading Prescribed Drugs 108
5.1.3 Clinical Practice 111
5.2 US 113
5.3 France 117
5.4 Germany 119
5.5 Italy 122
5.6 Spain 125
5.7 UK 126
5.8 Japan 129
5.9 China 131
6 Competitive Assessment 134
6.1 Overview 134
6.2 Product Profiles – Major Brands 138
6.2.1 Statins 138
6.2.2 Zetia (ezetimibe) 158
6.2.3 Vytorin (simvastatin/ezetimibe) 167
6.2.4 Liptruzet (atorvastatin/ezetimibe) 171
6.2.5 Niaspan (niacin extended-release) 175
6.2.6 Kynamro (mipomersen sodium) 181
6.2.7 Juxtapid (lomitapide) 188
6.2.8 TriCor/Trilipix (fenofibrate/fenfibric acid) 193
6.2.9 Omega-3 Fatty Acids 198
6.2.10 Welchol (colesevelam HCl) and the Bile Acid Sequestrants 213
7 Unmet Need and Opportunity 219
7.1 Overview 219
7.2 LDL-C-Lowering Drugs for Statin-Intolerant and Statin-Refractory Patients 220
7.2.1 Unmet Need 220
7.2.2 Gap Analysis 221
7.2.3 Opportunity 222
7.3 Improved Diagnosis, Patient Education, and Long-term Compliance 223
7.3.1 Unmet Need 223
7.3.2 Gap Analysis 224
7.3.3 Opportunity 226
7.4 Therapies that Prevent or Reverse the Build-Up of Atherosclerotic Plaque 227
7.4.1 Unmet Need 227
7.4.2 Gap Analysis 228
7.4.3 Opportunity 229
7.5 Therapies for Patients with HoFH with Improved Side Effect Profiles 230
7.5.1 Unmet Need 230
7.5.2 Gap Analysis 231
7.5.3 Opportunity 232
8 Pipeline Assessment 233
8.1 Overview 233
8.2 Clinical Trial Mapping 237
8.2.1 Clinical Trials by Patient Population 237
8.3 Promising Drugs in Clinical Development 237
8.3.1 Alirocumab 237
8.3.2 Bococizumab 246
8.3.3 Evolocumab 251
8.3.4 Anacetrapib 260
8.3.5 Evacetrapib 268
8.3.6 TA-8995 (DEZ-001) 274
8.3.7 CER-001 280
8.3.8 ETC-1002 286
8.4 Other Drugs in Development 294
9 Current and Future Players 295
9.1 Overview 295
9.2 Trends in Corporate Strategy 300
9.3 Company Profiles 302
9.3.1 AbbVie 302
9.3.2 Aegerion Pharmaceuticals, Inc. 304
9.3.3 Amarin 306
9.3.4 Amgen 308
9.3.5 AstraZeneca 310
9.3.6 Cerenis Therapeutics Inc. 313
9.3.7 Daiichi Sankyo 315
9.3.8 Dezima Pharma 317
9.3.9 Eli Lilly 319
9.3.10 Esperion Therapeutics, Inc. 322
9.3.11 Genzyme 324
9.3.12 GlaxoSmithKline 326
9.3.13 Merck & Co. 328
9.3.14 Pfizer 331
9.3.15 Regeneron Pharmaceuticals, Inc. 333
9.3.16 Sanofi 335
10 Market Outlook 339
10.1 Global Markets 339
10.1.1 Forecast 339
10.1.2 Drivers and Barriers – Global Issues 348
10.2 United States 351
10.2.1 Forecast 351
10.2.2 Key Events 356
10.2.3 Drivers and Barriers 357
10.3 5EU 359
10.3.1 Forecast 359
10.3.2 Key Events 367
10.3.3 Drivers and Barriers 368
10.4 Japan 371
10.4.1 Forecast 371
10.4.2 Key Events 374
10.4.3 Drivers and Barriers 375
10.5 China 377
10.5.1 Forecast 377
10.5.2 Key Events 381
10.5.3 Drivers and Barriers 381
11 Appendix 384
11.1 Bibliography 384
11.2 Abbreviations 412
11.3 Methodology 420
11.4 Forecasting Methodology 420
11.4.1 Diagnosed Dyslipidemia Patients 420
11.4.2 Percent Drug-Treated Patients 421
11.4.3 Drugs Included in Each Therapeutic Class 421
11.4.4 Launch and Patent Expiry Dates 422
11.4.5 General Pricing Assumptions 423
11.4.6 Individual Drug Assumptions 424
11.4.7 Generic Erosion 431
11.4.8 Pricing of Pipeline Agents 431
11.5 Physicians and Specialists Included in this Study 432
11.6 About the Authors 434
11.6.1 Analyst 434
11.6.2 Therapy Area Director 435
11.6.3 Epidemiologist 435
11.6.4 Global Head of Healthcare 436
11.7 About GlobalData 437
11.8 Disclaimer 437
【レポート販売概要】
■ タイトル：脂質異常症治療薬の世界市場予測および分析■ 英文：PharmaPoint: Dyslipidemia - Global Drug Forecast and Market Analysis to 2023
■ 発行日：2015年5月5日
■ 調査会社：GlobalData
■ 商品コード：GDHC110PIDR
■ 調査対象地域：グローバル
- ネットワーク暗号化の世界市場予測（～2023年）Growing demand to meet various regulatory compliances to drive the overall network encryption marketThe global network encryption market size is expected to grow from USD 2.9 billion in 2018 to USD 4.6 billion by 2023, at a Compound Annual Growth Rate (CAGR) of 9.8% during the forecast period. Major growth factors for the market include an increasing demand to meet different regulatory compliances …
- Tinnitus：グローバル臨床試験レビューH2, 2013Tinnitus Global Clinical Trials Review, H2, 2013 Summary GlobalData's clinical trial report, “Tinnitus Global Clinical Trials Review, H2, 2013" provides data on the Tinnitus clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Tinnitus. It includes an overview of the trial numbers and their recruitment status as per the site of trial condu …
- 遠隔医療ソリューションの世界市場：遠隔医療機器、遠隔医療ソフトウェア、遠隔医療サービスThe healthcare industry is undergoing a fundamental transformation globally—a shift from a volume-based business to a value-based business. Growing demands from consumers for improved healthcare quality and greater value are forcing healthcare providers and payers to deliver optimized outcomes. In addition, while the number of hospital admissions is rising globally, healthcare infrastructure is no …
- T細胞白血病(T-Cell Leukemia)：治療薬開発パイプライン動向（2015年上半期版）T-Cell Leukemia - Pipeline Review, H1 2015 Summary Global Markets Direct’s, ‘T-Cell Leukemia - Pipeline Review, H1 2015’, provides an overview of the T-Cell Leukemia’s therapeutic pipeline. This report provides comprehensive information on the therapeutic development for T-Cell Leukemia, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of acti …
- 高性能合金の世界市場：展伸アルミニウム合金、鋳物アルミニウム合金、非鉄合金、耐熱合金The high performance alloys market has varied applications such as aerospace, industrial, automotive, oil & gas, electronics & electrical, and others. The aerospace segment accounted for around 54% of the global high performance alloys market in 2014. The industrial segment is expected to grow due to increase in demand from emerging economies. The automotive segment is also one of the major end us …
- 世界のセイボリー及びデリカテッセン（調理済み惣菜）食品市場のニュース及びイベント動向（2014年7月）Synopsis The report provides a review of the latest news and key events in the global savory & deli foods market during July 2014. Summary Using this report, marketers will effectively gain an insight into the latest happenings in the global savory & deli foods market throughout the month. The monthly report provides the reader with the top-line data necessary to quickly keep abreast of latest eve …
- ブレナー腫瘍：世界の臨床試験レビュー（2014年上半期）Brenner Tumor Global Clinical Trials Review, H1, 2014 Summary GlobalData's clinical trial report, “Brenner Tumor Global Clinical Trials Review, H1, 2014" provides data on the Brenner Tumor clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Brenner Tumor. It includes an overview of the trial numbers and their recruitment status as per the …
- 砂糖市場：タイThis report is a comprehensive research of sugar industry in Thailand. The first two chapters of the report feature the country profile by giving general information on Thailand and by thoroughly studying its economic state, (including key macroeconomic indicators and their development trends). The third chapter covers common business procedures in the country: from starting a project to closing a …
- スマートセンサーの世界市場展望2017-20276According to Stratistics MRC, the Global Smart Sensors Market is accounted for $24.26 billion in 2017 and is expected to reach $123.32 billion by 2026 growing at a CAGR of 19.8% from 2017 to 2026. Some of the key factors driving the market growth are growing demand for consumer electronics products, higher demand in the healthcare and automotive industries and the growing trend of miniaturization …
- 世界の電気電子機器廃棄物（E-Waste）管理市場The growing amount of e-waste has become a major challenge for both developed and developing economies. The shortening life span of the electrical and electronic equipment and the rapid technological advancements are the major driving force for the global e-waste management market. E-waste comprises discarded electronic appliances, of which computers and mobile telephones are disproportionately ab …
- 世界の体液管理及び可視化システム可視化システム市場動向（～2018）The fluid management and visualization systems industry has evolved from traditional standalone systems to modern automated, integrated systems to increase the endosurgical procedure outcomes. Patient safety and security from infections have also gained greater importance in fluid management and visualization systems over the years. Over the past few years, the fluid management and visualization s …
- 航空機用装飾ラミネートの世界市場2019-2023Global Aircraft Decorative Laminates Market: About this market Technavio’s aircraft decorative laminates market analysis considers sales from both film laminates and reinforced laminates. Our analysis also considers the sales of aircraft decorative laminates in APAC, Europe, North America, South America, and MEA. In 2018, the film laminates segment had a significant market share, and this trend is …
- 世界及び中国の高強度ポリエステル糸市場2015The Global and China High-strength polyester Thread Industry 2015 Market Research Report is a professional and in-depth study on the current state of the High-strength Polyester Thread industry. The report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure. The High-strength Polyester Thread market analysis is provided for th …
- 世界の銀行/金融部門におけるアウトソーシング市場（2013-2018）About Outsourcing in the BFS Sector The BFS sector throughout the world is increasingly outsourcing its activities to third parties. Financial firms and banks are outsourcing their regulated and non-regulated activities. The BFS sector outsources its activities to reduce costs and to achieve strategic aims such as identifying investment areas. The BFS sector commonly outsources its IT services req …
- 世界の潜水艦市場（2014-2024）：地域別分析Synopsis This report offers detailed analysis of the global Submarine market over the next ten years, and provides extensive market size forecasts by country and sub sector. It covers the key technological and market trends in the Submarine market. Summary "The Global Submarine Market 2014-2024 - Country Analysis: Market Profile" provides details of the key markets in each region, offering an anal …
